Treatment of Pyelonephritis (Pyelitis)
For uncomplicated pyelonephritis, treat with fluoroquinolones for 5-7 days (ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg daily) or trimethoprim-sulfamethoxazole for 14 days (160/800 mg twice daily) based on antibiotic susceptibility testing. 1
Outpatient Oral Treatment (Mild Cases)
Fluoroquinolones are the preferred first-line agents for outpatient management:
- Ciprofloxacin 500-750 mg twice daily for 7 days (can be shortened to 5 days with clinical cure rates >93%) 1, 2
- Levofloxacin 750 mg once daily for 5 days 1, 2
- Fluoroquinolones should only be used when local resistance is <10% 1
Alternative oral agents when susceptibility is confirmed:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days - requires culture confirmation due to high resistance rates (clinical cure 92% in susceptible strains) 1, 2
- Cefpodoxime 200 mg twice daily for 10 days or Ceftibuten 400 mg daily for 10 days 1
- If oral cephalosporins are used empirically, administer an initial IV dose of ceftriaxone 1-2g 1, 2
Inpatient Intravenous Treatment (Severe Cases)
Patients requiring hospitalization should receive initial IV therapy:
- Ciprofloxacin 400 mg twice daily IV or Levofloxacin 750 mg daily IV 1
- Ceftriaxone 1-2 g daily or Cefotaxime 2 g three times daily 1
- Cefepime 1-2 g twice daily 1
- Piperacillin/tazobactam 2.5-4.5 g three times daily 1
- Aminoglycosides (Gentamicin 5 mg/kg daily or Amikacin 15 mg/kg daily) with or without ampicillin 1
Reserve carbapenems and novel broad-spectrum agents only for confirmed multidrug-resistant organisms:
- Imipenem/cilastatin, Meropenem, Ceftolozane/tazobactam, Ceftazidime/avibactam 1
Indications for Hospitalization
Admit patients with:
- Complicated infections (obstruction, anatomic abnormalities) 3
- Sepsis or hemodynamic instability 3, 4
- Persistent vomiting preventing oral intake 3
- Failed outpatient treatment 3
- Extremes of age or immunosuppression 3
Essential Diagnostic Steps
Always obtain urine culture and susceptibility testing before initiating antibiotics (positive in 90% of cases) 2, 3
Imaging is critical when:
- Patient remains febrile after 72 hours of appropriate antibiotics 1
- Clinical deterioration occurs 1
- Suspicion of obstruction or abscess 1, 4
- CT scan is the gold standard for detecting complications including emphysematous pyelitis 4
Critical Pitfalls to Avoid
Do not use TMP-SMX empirically without culture confirmation - resistance rates are high (18.4% in studies), leading to treatment failure 1, 2
Avoid nitrofurantoin, oral fosfomycin, and pivmecillinam for pyelonephritis - insufficient data on efficacy for upper tract infections 1, 2
Do not underdose fluoroquinolones - use pyelonephritis doses (ciprofloxacin 500-750 mg twice daily), not cystitis doses 2
Insufficient data exist for oral β-lactams as monotherapy - they achieve lower blood/urinary concentrations than IV formulations 1
Follow-Up and Treatment Failure
Repeat urine culture 1-2 weeks after completing antibiotics 2, 3
If no clinical improvement after 72 hours:
- Obtain repeat blood and urine cultures 3
- Perform imaging (CT scan) to identify obstruction, abscess, or anatomic abnormalities 1, 3
- Consider resistant organisms, immunosuppression, or need for surgical intervention 3
Note: Shorter antibiotic courses are associated with higher recurrence rates within 4-6 weeks but equivalent clinical cure rates, so tailor duration to local resistance patterns and patient risk factors 1